Bonviva 150mg Tablet 1s

Ibandronic acid, the active ingredient in the 150mg tablet, is a potent bisphosphonate that primarily acts by inhibiting osteoclast-mediated bone resorption. It selectively binds to hydroxyapatite in bone, targeting active bone remodeling sites. Once internalized by osteoclasts, ibandronic acid disrupts their function and induces apoptosis, leading to a reduction in bone resorption. This mechanism helps slow down bone breakdown, thereby preventing further bone loss and promoting the maintenance of bone mineral density. The preferential uptake by bone remodeling sites ensures that ibandronic acid exerts its therapeutic effect directly where bone resorption is most active, contributing to its efficacy in managing conditions characterized by excessive bone turnover.